Back to results
US 5,965,370 AGranted
Antisense modulation of RhoG expression
AssigneeIsis Pharmaceuticals, Inc.
InventorLex M. Cowsert
Life of this patent
Estimating the term…
Abstract
Antisense compounds, compositions and methods are provided for modulating the expression of RhoG. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding RhoG. Methods of using these compounds for modulation of RhoG expression and for treatment of diseases associated with expression of RhoG are provided.
Claims15
An antisense compound 8 to 30 nucleobases in length targeted to a nucleic acid molecule encoding human RhoG, wherein said antisense compound inhibits the expression of human RhoG.
Dependencies are inferred from the claim text.